FORT LAUDERDALE, Fla., May 6 -- The ability to read a newspaper or even prepare a meal -- functions that require near-vision abilities -- appear to improve when patients with the “wet” form of age-related macular degeneration undergo treatment with ranibizumab (Lucentis).
